Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 2/20 | 0.53 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.53 |
| ▸ | XIAP | P98170 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | SKP2 | Q13309 | 1/20 | 0.44 |
| ▸ | PPARG | P37231 | 1/20 | 0.44 |
| ▸ | PPARA | Q07869 | 1/20 | 0.44 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.44 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.44 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.44 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.44 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.44 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.44 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.44 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7257290 | 0.94 | LPL (0.61) | LPLLIPGPPARGPPARA | |
| SCHEMBL6272433 | 0.92 | LPL (0.62) | LPLLIPGPPARGPPARA | |
| SCHEMBL347126 | 0.89 | LPL (0.57) | LPLLIPGXIAPNPC1HPGD | |
| SCHEMBL8464457 | 0.88 | CYP4F2 (0.54) | LPLLIPGXIAPNPC1HPGD | |
| SCHEMBL26240023 | 0.88 | LPL (0.53) | LPLLIPGXIAPNPC1HPGD | |
| SCHEMBL6268248 | 0.87 | ENPP2 (0.47) | LPLLIPGENPP2GRIN2DGRIN3B | |
| SCHEMBL10235637 | 0.86 | LPL (0.56) | LPLLIPGXIAPNPC1HPGD | |
| SCHEMBL28141752 | 0.85 | LPL (0.63) | LPLLIPGXIAPPPARGPPARA | |
| SCHEMBL28409443 | 0.85 | LPL (0.53) | LPLLIPGXIAPNPC1HPGD | |
| SCHEMBL10235642 | 0.84 | LPL (0.57) | LPLLIPGXIAPPPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190023641-A1 | USE OF POLYMERIZATION INHIBITOR COMPOSITIONS | SPECIALTY OPERATIONS FRANCE (FR) | 2019-01-24 | — | — | US | claimed |
| US-12012475-B2 | Method of olefin polymerization using alkane-soluble non-metallocene precatalyst | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-06-18 | — | — | US | disclosed |
| CN-112823163-B | Alkane soluble non-metallocene precatalyst | 陶氏环球技术有限责任公司 | 2024-04-19 | — | — | CN | disclosed |
| US-11859031-B2 | Alkane-soluble non-metallocene precatalysts | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-01-02 | — | — | US | disclosed |
| EP-3877392-B1 | ALKANE-SOLUBLE NON-METALLOCENE PRECATALYSTS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-11-15 | — | — | EP | disclosed |
| CN-112839966-B | Process for the polymerization of olefins using an alkane soluble non-metallocene pre-catalyst | 陶氏环球技术有限责任公司 | 2023-07-28 | — | — | CN | disclosed |
| US-20230002373-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | NOVARTIS PHARMA AG (CH) | 2023-01-05 | — | — | US | disclosed |
| US-20220010045-A1 | ALKANE-SOLUBLE NON-METALLOCENE PRECATALYSTS | DOW GLOBAL TECHNOLOGIES LLC | 2022-01-13 | — | — | US | disclosed |
| US-20210403615-A1 | METHOD OF OLEFIN POLYMERIZATION USING ALKANE-SOLUBLE NON-METALLOCENE PRECATALYST | DOW GLOBAL TECHNOLOGIES LLC | 2021-12-30 | — | — | US | disclosed |
| EP-3247677-B1 | LIQUID ORGANIC COMPOSITION FOR ION EXTRACTION IN LIQUID PHASE | ADIONICS (FR) | 2021-12-08 | — | — | EP | disclosed |
| US-20040011638-A1 | Adding at least one stabilizer of acrylic monomers; injecting oxygen into the distillation column; adding a metal sequestrant for stabilizing acrylic monomers in a distillation column | ATOFINA (FR) | 2004-01-22 | — | — | US | disclosed |
| US-6476021-B1 | Compounds having cGMP-PDE inhibitory effect | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2002-11-05 | — | — | US | disclosed |
| EP-1048666-A1 | NOVEL COMPOUNDS HAVING cGMP-PDE INHIBITORY EFFECT | MOCHIDA PHARMACEUTICAL CO., LTD. (JP) | 2000-11-02 | — | — | EP | disclosed |
| US-5149884-A | Oxidative dehydrogenation of aromatic or aliphatic alcohols in gas phase | BASF AKTIENGESELLSCHAFT (DE) | 1992-09-22 | — | — | US | disclosed |
| EP-0278284-B1 | PULVERULENT WATER-DISPERSIBLE CAROTENOID COMPOUNDS AND PROCESS TO PREPARE THEM | BASF Aktiengesellschaft (DE) | 1991-05-22 | — | — | EP | disclosed |
| EP-0244632-B1 | TUBE BUNDLE REACTOR, ITS USE IN EXOTHERMAL ORGANIC REACTIONS AND PROCESS FOR THE PREPARATION OF KETONES AND ALDEHYDES | BASF Aktiengesellschaft (DE) | 1991-02-20 | — | — | EP | disclosed |
| EP-0278284-A1 | Pulverulent water-dispersible carotenoid compounds and process to prepare them | BASF Aktiengesellschaft (DE) | 1988-08-17 | — | — | EP | disclosed |
| EP-0004881-B1 | PROCESS FOR THE PREPARATION OF AROMATIC AND ARALIPHATIC ALDEHYDES | BASF Aktiengesellschaft (DE) | 1981-10-07 | — | — | EP | disclosed |
| US-4224254-A | OXIDATION OF AROMATIC ALCOHOLS, SILVER CATALYST | BASF AKTIENGESELLSCHAFT (DE) | 1980-09-23 | — | — | US | disclosed |
| EP-0004881-A2 | Process for the preparation of aromatic and araliphatic aldehydes | BASF Aktiengesellschaft (DE) | 1979-10-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11859031-B2 | Alkane-soluble non-metallocene precatalysts | AP1M1, CCNA1, AMY1A | LPL 2459/4885LIPG 4106/4885XIAP 4798/4885 |
| US-20230002373-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | STING1, CGAS, IRF3 | LPL 1616/4885LIPG 164/4885XIAP 183/4885 |
| US-20220010045-A1 | ALKANE-SOLUBLE NON-METALLOCENE PRECATALYSTS | AP1M1, CCNA1, AMY1A | LPL 2459/4885LIPG 4106/4885XIAP 4798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.